A series of metabolically stable butyrolactam 11beta-HSD1 inhibitors have been synthesized and biologically evaluated. These compounds exhibit excellent HSD1 potency and HSD2 selectivity, pharmacokinetic, and pharmacodynamic profiles.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2006.08.034 | DOI Listing |
Publication Analysis
Top Keywords
butyrolactam 11beta-hsd1
8
11beta-hsd1 inhibitors
8
discovery orally
4
orally active
4
active butyrolactam
4
inhibitors series
4
series metabolically
4
metabolically stable
4
stable butyrolactam
4
inhibitors synthesized
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!